Bhadra
Abhijit Bhadra, Andhra Pradesh IN
Patent application number | Description | Published |
---|---|---|
20130145349 | Metadata Merging In Agent Configuration Files - A technique for updating agent software which controls an agent, including how the agent adds instrumentation to an application and how the agent process data from the instrumentation. A current configuration file and an updated configuration file are evaluated in view of rules, to create a merged configuration file. The files include metadata entries. The rules can include: delete a current configuration file, not merge a current configuration file with an updated configuration file, overwrite a current configuration file with an updated configuration file, delete a metadata entry, prefer an entry in the configuration file over a corresponding entry in the updated configuration file, and prefer an entry in the updated configuration file over the corresponding entry in the configuration file. Customized entries in the current configuration file can be maintained if appropriate. Entries which are not maintained are kept in the merged configuration file as inline comments for documentation. | 06-06-2013 |
Bhaskar Bhadra, Secundrabad IN
Patent application number | Description | Published |
---|---|---|
20150037855 | FERMENTATIVE PRODUCTION OF ALCOHOLS - The invention relates to the fields of industrial microbiology and alcohol production. The invention also relates to the development of a microorganism capable of producing fermentation products via an engineered pathway, and uses of the microorganism. The invention also relates to the methods to improve cell viability and productivity and the use of recycling and acid washing to increase the yield of fermentation products. | 02-05-2015 |
Debashis Bhadra, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20110138515 | COMPOSITION AND A PROCESS TO OBTAIN WRINKLE FREE WOOLEN GARMENTS - The present disclosure relates to a composition comprising cross linking agents, polymers, proteins and alkaline reducing agents to obtain wrinkle free woolen garment. The present disclosure further relates to a method of obtaining said composition along with a process of obtaining the wrinkle free woolen garment. The disclosure also relates to the treated garment. | 06-16-2011 |
Dinesh Kanji Bhadra, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20120329762 | ANTI-THROMBOTIC COMPOUNDS - New compounds, namely, (7aS,2′S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases. | 12-27-2012 |
20120329763 | ANTI-THROMBOTIC COMPOUNDS - New compounds, namely, (7aS,2′S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases. | 12-27-2012 |
20130316986 | Anti-Thrombotic Compounds - New compounds, namely, (7aS,2′S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases. | 11-28-2013 |
20130316987 | Anti-Thrombotic Compounds - New compounds, namely, (7aS,2′S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases. | 11-28-2013 |
20140031320 | Anti-Thrombotic Compounds - New compounds, namely, (7aS,2′S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases. | 01-30-2014 |
20140038924 | Anti-Thrombotic Compounds - New compounds, namely, (7aS,2′S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases. | 02-06-2014 |
Madhulina Bhadra, Newark, NJ US
Patent application number | Description | Published |
---|---|---|
20150096935 | NANOCARBON IMMOBILIZED MEMBRANES - Membranes including functionalized carbon nanotubes, nanodiamonds and/or graphene oxide immobilized in or on the membranes are disclosed. The membranes including the immobilized nanocarbons increase interactions with water vapor to improve desalination efficiency in membrane distillation. The membranes may be deployed in all modes of membrane distillation such as air gap membrane distillation, direct contact membrane distillation, vacuum membrane distillation and other separations. | 04-09-2015 |
Niloy Bhadra, Cleveland Hts., OH US
Patent application number | Description | Published |
---|---|---|
20140358191 | ADJUSTABLE NERVE ELECTRODE - Example adjustable electrodes are described. One example adjustable electrode includes two or more contacts configured to selectively deliver high frequency alternating current (HFAC) to a nerve in an amount sufficient to produce an HFAC nerve conduction block in the nerve. The example adjustable electrode may also include a logic configured to selectively control which of the two or more contacts deliver HFAC to the nerve to control whether the nerve electrode is in a first (e.g., onset response mitigating) configuration or in a second (e.g., HFAC nerve conduction block maintenance) configuration. The electrode may be used in applications including, but not limited to, nerve block applications, and nerve stimulation applications. The electrode may be adjusted by changing attributes including, but not limited to, the number, length, orientation, distance between, surface area, and distance from a nerve of contacts to be used to deliver the HFAC. | 12-04-2014 |
Niloy Bhadra, Cleveland Heights, OH US
Patent application number | Description | Published |
---|---|---|
20080294221 | Action potential conduction prevention - An example method for selectively and reversibly preventing the conduction of action potentials in a targeted nerve region is presented. The method includes generating an electrical waveform having two phases and selectively depolarizing a nerve membrane using the electrical waveform. The nerve membrane is depolarized to a state where the nerve membrane cannot conduct an action potential. The depolarization is achieved by selectively repetitively providing the electrical waveform to a targeted nerve region associated with the nerve region to control m gates and h gates in the region and thus to control the availability of ions. | 11-27-2008 |
20100241190 | ONSET-MITIGATING HIGH-FREQUENCY NERVE BLOCK - A method of blocking signal transmission through a nerve with reduced onset activity includes applying an HFAC to an axon of a nerve to block the transmission of signals through the axon. The method may also include applying a direct current (DC) to the axon, increasing the amplitude of the DC over time to a predetermined amplitude, applying the HFAC, and then decreasing the DC. The method may also include temporarily reducing the amplitude of the HFAC to permit the transmission of signals through the axon and subsequently increasing the amplitude to block transmission without triggering an onset response. The method may also include temporarily applying an unbalanced charge to the nerve and then balancing the charge over time. | 09-23-2010 |
20110160798 | SEPARATED-INTERFACE NERVE ELECTRODE - Example ionic coupling electrodes are described. One example ionic conducting electrode includes a first portion that can be coupled to a single phase current source. The first portion carries current flow via electrons. The electrode includes a second portion to apply a current to a nerve tissue. The second portion carries current flow via ions. The second portion is positioned between the nerve tissue and the first portion to prevent the first portion from touching the nerve tissue. The current applied to the nerve tissue is produced in the second portion in response to a current that is present in the first portion. The current present in the first portion is provided from a single phase current source. The electrode may be used in applications including, but not limited to, nerve block applications and nerve stimulation applications. | 06-30-2011 |
20140336728 | SYSTEMS AND METHODS THAT PROVIDE AN ELECTRICAL WAVEFORM FOR NEURAL STIMULATION OR NERVE BLOCK - One aspect of the present disclosure relates to a system that can provide an electric waveform for neural stimulation or nerve block. The system can include a first circuit component configured to provide a self-oscillating, voltage-boosted electric waveform. In some instances, the first circuit component can provide a “pause” waveform (e.g., with a period (T) that includes a swing time (ts) in which the waveform varies in a biphasic manner and a pause time (tp) in which the waveform has a constant amplitude). The system can also include a second circuit component configured to ensure that the oscillating signal is charge-balanced across at least one period of the self-oscillating, voltage-boosted electric waveform. | 11-13-2014 |
Niloy Bhadra US
Patent application number | Description | Published |
---|---|---|
20110125216 | ADJUSTABLE NERVE ELECTRODE - Example adjustable electrodes are described. One example adjustable electrode includes two or more contacts configured to selectively deliver high frequency alternating current (HFAC) to a nerve in an amount sufficient to produce an HFAC nerve conduction block in the nerve. The example adjustable electrode also includes a logic configured to selectively control which of the two or more contacts deliver HFAC to the nerve to control whether the nerve electrode is in a first (e.g., onset response mitigating) configuration or in a second (e.g., HFAC nerve conduction block maintenance) configuration. The electrode may be used in applications including, but not limited to, nerve block applications, and nerve stimulation applications. The electrode may be adjusted by changing attributes including, but not limited to, the number, length, orientation, distance between, surface area, and distance from a nerve of contacts to be used to deliver the HFAC. | 05-26-2011 |
Sambit Bhadra, Kolkata IN
Patent application number | Description | Published |
---|---|---|
20130194419 | Automatic Detection of Moving Object by Using Stereo Vision Technique - The present invention discloses a system and method for identifying a moving object in front of a vehicle by using stereo vision based technique. The invention also discloses a method and a system for determining an instantaneous distance between the moving object and the vehicle by processing the image of the moving object through a processor and by filtering and refining the image by using a Kalman filter to remove noise. | 08-01-2013 |
Sharmistha Bhadra, Winnipeg CA
Patent application number | Description | Published |
---|---|---|
20130106447 | DETECTION OF REINFORCEMENT METAL CORROSION | 05-02-2013 |
20150053575 | PASSIVE WIRELESS SENSOR - Systems, devices, and/or methods for use in passive wireless transmission of one or more parameters such as, e.g., pH, temperature, etc. are described. The systems, devices, and/or methods may use a passive sensor located proximate a material and an interrogator that may be used to interrogate the passive sensor and to receive a signal from the passive sensor representative of the one or more parameters. | 02-26-2015 |
Shoham Bhadra, North Brunswick, NJ US
Patent application number | Description | Published |
---|---|---|
20110150806 | COMPOSITION CONTAINING AN AQUEOUS DISPERSION OF POLYURETHANE AND AN OIL-SOLUBLE POLAR MODIFIED POLYMER - The invention relates to a composition comprising at least one aqueous polyurethane dispersion, at least one oil-soluble polar modified polymer, at least one alkoxylated fatty alcohol, and at least one polyamine compound having at least two amine groups. | 06-23-2011 |
Utpal Bhadra, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20130052137 | PARA AMINO BENZOIC ACID BASED NANOTUBES - The invention relates to nanotubes and processes for making them and intermediates of a drug moiety or its derivative/s as a structural moiety with side chain/s capable of promoting self aggregation. The side chain/s are mono or a multiple of alkyl chain/s that are substituted or unsubstituted capable of creating self aggregating assemblies. A p-amino benzoic acid (PABA) moiety or derivative as a structural moiety of 4-alkylamido-N-pyridin-2yl-benzamide with a lauric or stearic side chain. 4-alkylamido-N-pyridin-2yl-benzamide and 4-Amino-N-pyridine-2 yl-benzamide, N-(Pyridine-2-yl)-4-dodecanamido-benzamide and N-(Pyridin-2-yl)-4-stearamidobenzamide are intermediates useful for in vivo Conjugation of an active ingredient, illustrated by Rhodamine B. With Rhodamine B as an active ingredient, nano-tubes prepared with lauric side chain, which show red fluorescence and is useful for in vivo tracking. | 02-28-2013 |